Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
32 hedge funds and large institutions have $4.14M invested in Nymox Pharmaceutical Corp in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
4% more capital invested
Capital invested by funds: $3.98M → $4.14M (+$170K)
0% more funds holding
Funds holding: 32 → 32 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
26% less call options, than puts
Call options by funds: $288K | Put options by funds: $390K
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$447K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$229K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$133K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$107K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$75.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$190K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$140K |
| 3 |
Renaissance Technologies
New York
|
-$97.4K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$94K |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$91K |
NYMX Hedge Fund Activity: Q1 2014 in Review
32 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2014, worth a combined $4.14M — up 4.3% from $3.98M a quarter earlier.
Fund positioning in NYMX was balanced in Q1 2014: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 9 trimmed.
The largest buyer was Advisors Asset Management, opening a new position worth an estimated $447K. The largest seller was CIBC World Market, exiting entirely with an estimated $190K sold.
- 32 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $4.14M of Nymox Pharmaceutical Corp stock for Q1 2014, up 4.3% quarter-over-quarter.
- 6 funds opened new Nymox Pharmaceutical Corp positions in Q1 2014 and 6 closed out, a net change of 0 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2014 was Advisors Asset Management, an estimated $447K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2014 was CIBC World Market, an estimated $190K sold.
Based on aggregated 13F filings for Q1 2014.